Alnylam Pharmaceuticals, Inc. (ALNY)
236.06
-0.16
(-0.07%)
USD |
NASDAQ |
Aug 24, 16:00
237.08
+1.02
(+0.43%)
After-Hours: 20:00
Alnylam Pharmaceuticals Total Assets (Quarterly) : 5.559B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 5.559B |
| March 31, 2026 | 5.130B |
| December 31, 2025 | 5.026B |
| September 30, 2025 | 4.852B |
| June 30, 2025 | 4.566B |
| March 31, 2025 | 4.214B |
| December 31, 2024 | 4.302B |
| September 30, 2024 | 4.205B |
| June 30, 2024 | 4.010B |
| March 31, 2024 | 3.824B |
| December 31, 2023 | 3.830B |
| September 30, 2023 | 3.839B |
| June 30, 2023 | 3.402B |
| March 31, 2023 | 3.392B |
| December 31, 2022 | 3.546B |
| September 30, 2022 | 3.535B |
| June 30, 2022 | 3.330B |
| March 31, 2022 | 3.434B |
| December 31, 2021 | 3.643B |
| September 30, 2021 | 3.472B |
| June 30, 2021 | 3.509B |
| March 31, 2021 | 3.255B |
| December 31, 2020 | 3.407B |
| September 30, 2020 | 3.307B |
| June 30, 2020 | 3.374B |
| Date | Value |
|---|---|
| March 31, 2020 | 2.280B |
| December 31, 2019 | 2.395B |
| September 30, 2019 | 2.542B |
| June 30, 2019 | 2.716B |
| March 31, 2019 | 2.014B |
| December 31, 2018 | 1.575B |
| September 30, 2018 | 1.676B |
| June 30, 2018 | 1.789B |
| March 31, 2018 | 1.923B |
| December 31, 2017 | 1.995B |
| September 30, 2017 | 1.358B |
| June 30, 2017 | 1.434B |
| March 31, 2017 | 1.134B |
| December 31, 2016 | 1.263B |
| September 30, 2016 | 1.313B |
| June 30, 2016 | 1.382B |
| March 31, 2016 | 1.317B |
| December 31, 2015 | 1.387B |
| September 30, 2015 | 1.436B |
| June 30, 2015 | 1.531B |
| March 31, 2015 | 1.629B |
| December 31, 2014 | 1.080B |
| September 30, 2014 | 986.36M |
| June 30, 2014 | 1.033B |
| March 31, 2014 | 1.080B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | 2.995B |
| Regeneron Pharmaceuticals, Inc. | 41.73B |
| Vertex Pharmaceuticals, Inc. | 27.42B |
| BridgeBio Pharma, Inc. | 1.217B |
| Pfizer Inc. | 201.13B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 4.205B |
| Shareholders Equity (Quarterly) | 1.354B |
| Debt to Equity Ratio | 2.206 |
| Current Ratio | 3.055 |
| Net Debt Paydown Yield | -0.13% |